Previous studies have also identified elevated levels of plasma TGF-β, an important regulator of lung and immune system development, in COPD patients compared with healthy controls (Mak et al, 2009; Verhamme et al, 2015). Here, TGFB1 is linked to chronic obstructive pulmonary disease.